Skip to main content

Table 4 Factors associated with time to LTFU for patients on ART in central Kenya between 2004 and 2012 after 36 months of follow up

From: Survival probability and factors associated with time to loss to follow-up and mortality among patients on antiretroviral treatment in central Kenya

  Univariable Multivariable
SHR (95% CI) p value SHR (95% CI) p value
Age groups
 0–4 Ref   Ref  
 5–9 0.82 (0.70–0.95) 0.009 0.76 (0.59–0.98) 0.035
 10–14 0.86 (0.72–1.03) 0.096 0.78 (0.59–1.04) 0.088
 15–19 1.18 (0.97–1.43) 0.095 1.08 (0.81–1.44) 0.604
 20–35 1.22 (1.10–1.36)  < 0.001 1.26 (1.03–1.55) 0.024
 36–50 0.90 (0.81–1.01) 0.063 0.91 (0.74–1.12) 0.363
 51 and above 0.86 (0.76–0.98) 0.022 0.85 (0.68–1.06) 0.139
Sex
 Female Ref   Ref  
 Male 1.03 (0.98–1.08) 0.308 1.07 (1.01–1.14) 0.026
Marital status
 Single 1.19 (1.12–1.26)  < 0.001 1.18 (1.09–1.27)  < 0.001
 Married Ref   Ref  
 Divorced 1.30 (1.21–1.38)  < 0.001 1.26 (1.17–1.36)  < 0.001
 Widowed 0.93 (0.86–1.02) 0.106 1.04 (0.94–1.14) 0.460
Regimen started
 TDF based Ref   Ref  
 D4T based 0.61 (0.45–0.82) 0.004 1.87 (1.70–2.06)  < 0.001
 AZT based 0.48 (0.35–0.65) 0.632 1.29 (1.19–1.41)  < 0.001
 ABC based 0.78 (0.45–1.36) 0.042 1.55 (1.29–1.86)  < 0.001
Baseline WHO stage
 Stage 1 Ref   Ref  
 Stage 2 1.05 (0.98–1.12) 0.188 1.12 (1.03–1.21) 0.006
 Stage 3 1.20 (1.12–1.28)  < 0.001 1.21 (1.12–1.32)  < 0.001
 Stage 4 1.50 (1.36–1.66)  < 0.001 1.51 (1.32–1.71)  < 0.001
TB status
 ON TB TX Ref   Ref  
 No signs 1.88 (1.50–2.36)  < 0.001 1.93 (1.50–2.49)  < 0.001
 Presumptive TB 4.59 (4.17–5.05)  < 0.001 4.08 (3.64–4.57)  < 0.001
ART cohort
 2004 Ref    
 2005 0.73 (0.58–0.93) 0.010 0.78 (0.55–1.12) 0.175
 2006 0.71 (0.57–0.88) 0.002 0.99 (0.72–1.36) 0.929
 2007 1.02 (0.83–1.26) 0.837 1.47 (1.08–2.00) 0.015
 2008 0.89 (0.72–1.10) 0.275 1.46 (1.07–2.00) 0.016
 2009 0.81 (0.66–1.00) 0.049 1.53 (1.12–2.08) 0.007
 2010 0.87 (0.71–1.07) 0.189 1.94 (1.42–2.65)  < 0.001
 2011 0.90 (0.73–1.11) 0.324 2.45 (1.79–3.37)  < 0.001
 2012 1.21 (0.99–1.49) 0.068 3.47 (2.52–4.76)  < 0.001